Literature DB >> 23359162

Analysis of the potential for pancreatic cancer metastasis in vitro and in vivo.

Chen Huang1, Keping Xie.   

Abstract

Pancreatic cancer remains a challenging disease, with an overall 5-year survival rate below 5%, the main reason being that it has an extremely high potential for invasion and metastasis. This potential may contribute to the fact that in more than three fourths of patients diagnosed with pancreatic cancer, it has already spread locally and to distant organs, precluding curative resection. Therefore, improved understanding of the mechanisms underlying pancreatic cancer metastasis is urgently needed. In this chapter, we describe our approaches to determining the metastatic potential of pancreatic cancer cells. Specifically, we report the details of these approaches, including in vitro assays of migration, invasion, adhesion, and angiogenesis and in vivo models of liver and lung metastasis and angiogenesis.

Entities:  

Mesh:

Year:  2013        PMID: 23359162     DOI: 10.1007/978-1-62703-287-2_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  MicroRNA-452 suppresses pancreatic cancer migration and invasion by directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1.

Authors:  Hongyan Li; Yan Wu; Peixiu Li
Journal:  Oncol Lett       Date:  2017-07-10       Impact factor: 2.967

2.  Identification of Sox6 as a regulator of pancreatic cancer development.

Authors:  Weiliang Jiang; Qiongying Yuan; Yuanye Jiang; Li Huang; Congying Chen; Guoyong Hu; Rong Wan; Xingpeng Wang; Lijuan Yang
Journal:  J Cell Mol Med       Date:  2018-01-25       Impact factor: 5.295

3.  MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1.

Authors:  Kai Cheng; Lan Feng; Shuang Yu; Changhong Yu; Nannan Chi
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.